[Elsevier] Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial |
|
This post will be closed automatically in 2026-07-19 00:49
Reward10points
|
10
Mechanism of carbonating recycled concrete fines in aqueous environment: The particle size effect
10
Infectious and non-infectious causes of sterile pyuria: Diagnostic challenge
10
Simulation and analysis of full-coverage ultrasonic signal detection for reinforcement part of nuclear reactor pressure vessel outlet nozzle
10
A study on auxetic-inspired side structure for enhanced crashworthiness
10
Nano-indentation and SEM analysis of the interfacial transition zone in RAP-concrete
